Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

INTERCEPT PHARMA EUROPE LTD.

Company number 09224395

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Oct 2018 CS01 Confirmation statement made on 30 September 2018 with updates
06 Sep 2018 SH01 Statement of capital following an allotment of shares on 5 September 2018
  • GBP 144
03 Sep 2018 SH01 Statement of capital following an allotment of shares on 3 September 2018
  • GBP 143
30 Aug 2018 SH01 Statement of capital following an allotment of shares on 30 August 2018
  • GBP 142
30 Aug 2018 SH01 Statement of capital following an allotment of shares on 28 August 2018
  • GBP 141
24 Aug 2018 SH01 Statement of capital following an allotment of shares on 23 August 2018
  • GBP 140
23 Aug 2018 SH01 Statement of capital following an allotment of shares on 22 August 2018
  • GBP 139
22 Aug 2018 SH01 Statement of capital following an allotment of shares on 21 August 2018
  • GBP 138
16 Aug 2018 SH01 Statement of capital following an allotment of shares on 14 August 2018
  • GBP 137
16 Aug 2018 SH01 Statement of capital following an allotment of shares on 14 August 2018
  • GBP 136
16 Aug 2018 SH01 Statement of capital following an allotment of shares on 14 August 2018
  • GBP 133
16 Aug 2018 SH01 Statement of capital following an allotment of shares on 14 August 2018
  • GBP 130
16 Aug 2018 SH01 Statement of capital following an allotment of shares on 14 August 2018
  • GBP 127
04 Jan 2018 TM01 Termination of appointment of Bryan Yoon as a director on 4 December 2017
04 Jan 2018 TM02 Termination of appointment of Bryan Yoon as a secretary on 4 December 2017
04 Jan 2018 SH01 Statement of capital following an allotment of shares on 4 December 2017
  • GBP 124
05 Dec 2017 AA Full accounts made up to 31 December 2016
04 Oct 2017 CS01 Confirmation statement made on 30 September 2017 with updates
02 Oct 2017 PSC05 Change of details for Intercept Pharmaceuticals, Inc. as a person with significant control on 28 September 2017
24 Jul 2017 SH01 Statement of capital following an allotment of shares on 18 July 2017
  • GBP 121
21 Jul 2017 SH01 Statement of capital following an allotment of shares on 18 July 2017
  • GBP 119
03 Apr 2017 SH01 Statement of capital following an allotment of shares on 1 March 2017
  • GBP 118
28 Dec 2016 SH01 Statement of capital following an allotment of shares on 19 December 2016
  • GBP 115
25 Oct 2016 SH01 Statement of capital following an allotment of shares on 28 September 2016
  • GBP 111
24 Oct 2016 SH01 Statement of capital following an allotment of shares on 28 September 2016
  • GBP 109